Premium
P17.07: Chorioangiomas with signs of fetal compromise on ultrasound evaluation: a case series
Author(s) -
Hardy I.,
Bérubé G.,
Raîche E.,
RoyLacroix M.,
Ouellet A.
Publication year - 2019
Publication title -
ultrasound in obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.202
H-Index - 141
eISSN - 1469-0705
pISSN - 0960-7692
DOI - 10.1002/uog.21046
Subject(s) - medicine , ductus venosus , polyhydramnios , apgar score , caesarean section , fetus , obstetrics , middle cerebral artery , anemia , umbilical artery , cord , pregnancy , cardiology , surgery , genetics , biology , ischemia
Chorioangiomas (ChAs) are benign placental tumors that occur in around 0.6% of pregnancies (1). Giant ChAs, which are greater than 4cm in diameter, can disrupt fetal circulation and pregnancies with this condition are more likely to present growth restriction, fetal heart failure, polyhydramnios, fetal anemia, premature delivery, and intra-uterine demise (IUD) (2). When ChAs are diagnosed antenatally, close ultrasound examination is recommended, but the optimal ultrasound management is unknown (3). We report our experience in the management of four cases of ChAs diagnosed at our center between 2016 and 2019. All cases were diagnosed at the routine second trimester scan and followed thereafter with serial ultrasounds performed at least every two weeks to evaluate fetal growth, and wellbeing, and systematic Doppler evaluation of the middle cerebral artery peak systematic velocity (MCA PSV), ductus venosus (DV), and umbilical artery (UA). The diagnoses of ChA were confirmed by placental pathologic examination. CASE 1